Work

Abstract PR05: An assessment of the prognostic and predictive associations of 13 angiogenic biomarkers in women with newly diagnosed advanced ovarian cancer treated with chemotherapy with or without bevacizumab

Year: 2015

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1538-8514.tumang15-pr05

Authors: Wei Wei, Mark F. Brady, Tsun-Yee Tsang, Vinod Vathipadiekal, Robert A. Burger, Robert S. Mannel, Parviz Hanjani, Warner K. Huh, Elizabeth M. Swisher, Thomas J. Rutherford, Janos L. Tanyi, Julian C. Schink, Shashikant B. Lele, Paul A. DiSilvestro, Michael J. Birrer

Institutions: Massachusetts General Hospital, University of Pennsylvania, University of Oklahoma, Abington Memorial Hospital, University of Alabama at Birmingham, University of Washington, Fred Hutch Cancer Center, Yale University, Spectrum Health, Roswell Park Comprehensive Cancer Center, Women & Infants Hospital of Rhode Island

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2376149174

Cites:

Cited by: 2

Related to: 10